Amedeo Smart

Free Medical Literature Service

 

Amedeo

Malignant Melanoma
  Free Subscription

Articles published in
J Biol Chem
    March 2024
  1. LEE YH, Yoon AR, Yun CO, Chung KC, et al
    Dual-specificity kinase DYRK3 phosphorylates p62 at the Thr-269 residue and promotes melanoma progression.
    J Biol Chem. 2024 Mar 20:107206. doi: 10.1016/j.jbc.2024.107206.
    >> Share

    December 2023
  2. GERARD L, Duviver L, Fourrez M, Salazar P, et al
    Identification of two novel heterodimeric ABC transporters in melanoma: ABCB5beta/B6 and ABCB5beta/B9.
    J Biol Chem. 2023 Dec 23:105594. doi: 10.1016/j.jbc.2023.105594.
    >> Share

    November 2023
  3. BAQAI U, Kurimchak AM, Trachtenberg I, Purwin TJ, et al
    Kinome profiling identifies MARK3 and STK10 as potential therapeutic targets in uveal melanoma.
    J Biol Chem. 2023 Nov 1:105418. doi: 10.1016/j.jbc.2023.105418.
    >> Share

    July 2023
  4. BELANGER F, Roussel C, Sawchyn C, St-Hilaire E, et al
    A genome-wide screen reveals that Dyrk1A kinase promotes nucleotide excision repair by preventing aberrant overexpression of cyclin D1 and p21.
    J Biol Chem. 2023;299:104900.
    >> Share

    June 2023
  5. ZHANG J, Ye ZW, Brautigam L, Chakraborty P, et al
    A Role for Microsomal Glutathione Transferase 1 in Melanin Biosynthesis and Melanoma Progression.
    J Biol Chem. 2023 Jun 13:104920. doi: 10.1016/j.jbc.2023.104920.
    >> Share

    May 2023
  6. TKACIK E, Li K, Gonzalez-Del Pino G, Ha BH, et al
    Structure and RAF family kinase isoform selectivity of type II RAF inhibitors tovorafenib and naporafenib.
    J Biol Chem. 2023;299:104634.
    >> Share

    April 2023
  7. BASU A, Champagne RN, Patel NG, Nicholson ED, et al
    TFCP2 is a transcriptional regulator of heparan sulfate assembly and melanoma cell growth.
    J Biol Chem. 2023 Apr 13:104713. doi: 10.1016/j.jbc.2023.104713.
    >> Share

    March 2023
  8. YACHIDA N, Hoshino F, Murakami C, Ebina M, et al
    Saturated fatty acid- and/or monounsaturated fatty acid-containing phosphatidic acids selectively interact with heat shock protein 27.
    J Biol Chem. 2023;299:103019.
    >> Share

    August 2022
  9. PIETROBONO S, De Paolo R, Mangiameli D, Marranci A, et al
    p38 MAPK-dependent phosphorylation of transcription factor SOX2 promotes an adaptive response to BRAF inhibitors in melanoma cells.
    J Biol Chem. 2022 Aug 6:102353. doi: 10.1016/j.jbc.2022.102353.
    >> Share

    May 2022
  10. MURPHY JM, Jeong K, Erin Ahn EY, Steve Lim ST, et al
    Nuclear focal adhesion kinase induces APC/C activator protein CDH1-mediated cyclin-dependent kinase4/6 degradation and inhibits melanoma proliferation.
    J Biol Chem. 2022 May 4:102013. doi: 10.1016/j.jbc.2022.102013.
    >> Share

    April 2022
  11. ZHANG Q, Haak AJ, Sjogren B
    Regulator of G protein signaling 2 inhibits Galphaq-dependent uveal melanoma cell growth.
    J Biol Chem. 2022 Apr 19:101955. doi: 10.1016/j.jbc.2022.101955.
    >> Share

    December 2021
  12. ONKEN MD, Noda SE, Kaltenbronn KM, Frankfater C, et al
    Oncogenic Gq/11 signaling acutely drives and chronically sustains metabolic reprogramming in uveal melanoma.
    J Biol Chem. 2021 Dec 14:101495. doi: 10.1016/j.jbc.2021.101495.
    >> Share

    September 2021
  13. ANIKEEVA N, Panteleev S, Mazzanti NW, Terai M, et al
    Efficient killing of tumor cells by CAR-T cells requires greater number of engaged CARs than TCRs.
    J Biol Chem. 2021;297:101033.
    >> Share

    February 2021
  14. SAYEDYAHOSSEIN S, Huang K, Li Z, Zhang C, et al
    Pannexin 1 binds beta-catenin to modulate melanoma cell growth and metabolism.
    J Biol Chem. 2021 Feb 26:100478. doi: 10.1016/j.jbc.2021.100478.
    >> Share

  15. ONKEN MD, Makepeace CM, Kaltenbronn KM, Choi J, et al
    Targeting primary and metastatic uveal melanoma with a G protein inhibitor.
    J Biol Chem. 2021 Feb 9:100403. doi: 10.1016/j.jbc.2021.100403.
    >> Share

    January 2021
  16. MCANDREWS KM, Che SPY, LeBleu VS, Kalluri R, et al
    Effective delivery of STING agonist using exosomes suppresses tumor growth and enhances antitumor immunity.
    J Biol Chem. 2021;296:100523.
    >> Share

  17. HORN IP, Marks DL, Koenig AN, Hogenson TL, et al
    A rare germline CDKN2A variant (47T>G; p16-L16R) predisposes carriers to pancreatic cancer by reducing cell cycle inhibition.
    J Biol Chem. 2021;296:100634.
    >> Share

    December 2020
  18. CERAUDO E, Horioka M, Mattheisen JM, Hitchman TD, et al
    Direct evidence that the GPCR CysLTR2 mutant causative of uveal melanoma is constitutively active with highly biased signaling.
    J Biol Chem. 2020 Dec 6. pii: RA120.015352. doi: 10.1074/jbc.RA120.015352.
    >> Share

    August 2020
  19. KOZLOV G, Funato Y, Chen YS, Zhang Z, et al
    PRL3 pseudophosphatase activity is necessary and sufficient to promote metastatic growth.
    J Biol Chem. 2020;295:11682-11692.
    >> Share

    March 2020
  20. GROLLA AA, Miggiano R, Di Marino D, Bianchi M, et al
    A nicotinamide phosphoribosyltransferase-GAPDH interaction sustains the stress-induced NMN/NAD(+) salvage pathway in the nucleus.
    J Biol Chem. 2020;295:3635-3651.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016